Editas Medicine, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Editas Medicine, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Editas Medicine, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $329M, a 11% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $329M +$32.5M +11% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $296M +$45M +17.9% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $251M +$72.8M +40.8% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $178M +$33.8M +23.4% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $145M +$35.4M +32.5% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $109M +$35.8M +48.8% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $73.3M +$19M +35% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $54.3M +$34.4M +172% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $19.9M Dec 31, 2015 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.